|
A Multicenter, Double-Blind, Placebo-Controlled, Parallel-Design Evaluation of LAMICTAL for Add-on Treatment of Partial Seizures in Pediatric Patients |
lamotrigine |
105-040 |
|
Epilepsy, Partial |
Phase 3 |
|
|
|
|
An analysis-ready dataset is not available for this study. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies. |
March 2016 |